All 252 IBB (ISHARES BIOTECHNOLOGY ETF) Holdings
There are 252 IBB holdings. Top 10 companies weight: 44.73%.
Total Market Cap: $1.60T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (252 stocks) | +19.98% | 23.69 | 17.29 | 0.53 | +25.34% | +9.82% | 0.81 | ||||||||||
151 | PGEN | Precigen Inc | 0.06% | $5.49 | $1.82B | Biotechnology | Healthcare | -3.91% | N/A | 250.00 | N/A | N/A | N/A | 75 | +126.78% | $12 | -0.25% | 1.67 |
152 | SLDB | Solid Biosciences Inc | 0.06% | $8.46 | $947M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +106.86% | $18 | -28.03% | 1.77 |
153 | CGEM | Cullinan Therapeutics Inc | 0.06% | $18.06 | $1.10B | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +74.70% | $32 | -7.12% | 1.06 |
154 | GERN | Geron Corp | 0.06% | $1.44 | $951M | Biotechnology | Healthcare | -18.28% | N/A | N/A | N/A | N/A | N/A | 66 | +136.11% | $3.40 | +2.22% | 1.16 |
155 | ABUS | Arbutus Biopharma Corp | 0.06% | $4.52 | $898M | Biotechnology | Healthcare | N/A | 5.60 | 10.25 | N/A | N/A | N/A | 75 | +14.60% | $5.18 | +9.97% | 0.89 |
156 | BIOA | Bioage Labs Inc | 0.06% | $22.65 | $1.01B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +118.54% | $50 | 0.00% | 1.04 |
157 | ANNX | Annexon Inc Ordinary Shares | 0.06% | $5.39 | $1.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +176.07% | $15 | -24.51% | 1.22 |
158 | ANRO | Alto Neuroscience Inc | 0.06% | $27.07 | $973M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +29.80% | $35 | 0.00% | 1.26 |
159 | CSTL | Castle Biosciences Inc | 0.06% | $24.51 | $728M | Diagnostics & Research | Healthcare | -7.41% | N/A | N/A | N/A | N/A | N/A | 75 | +74.54% | $43 | -18.53% | 0.85 |
160 | CTMX | Cytomx Therapeutics Inc | 0.05% | $3.42 | $652M | Biotechnology | Healthcare | N/A | 24.82 | 14.20 | 0.76 | N/A | N/A | 83 | +265.50% | $13 | -9.49% | 2.01 |
161 | RGNX | Regenxbio Inc | 0.05% | $10.34 | $633M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +134.72% | $24 | -22.65% | 1.83 |
162 | SVRA | Savara Inc | 0.05% | $5.84 | $1.19B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +87.33% | $11 | +33.84% | 1.22 |
163 | IRWD | Ironwood Pharmaceuticals Inc Class A | 0.05% | $3.91 | $658M | Drug Manufacturers - Specialty & Generic | Healthcare | -12.17% | 8.62 | 12.33 | N/A | N/A | N/A | 68 | +62.40% | $6.35 | -21.35% | 1.07 |
164 | MRVI | N/A | 0.05% | $7.10 | $451M | Biotechnology | Healthcare | N/A | N/A | 370.37 | N/A | N/A | N/A | 65 | -16.90% | $5.90 | -29.84% | 1.21 |
165 | ORIC | Oric Pharmaceuticals Inc | 0.05% | $10.83 | $1.15B | Biotechnology | Healthcare | -10.25% | N/A | N/A | N/A | N/A | N/A | 76 | +87.35% | $20 | -9.37% | 1.45 |
166 | PHAT | N/A | 0.05% | $11.25 | $878M | Biotechnology | Healthcare | -24.73% | N/A | N/A | N/A | N/A | N/A | 77 | +110.67% | $24 | -19.21% | 1.26 |
167 | SANA | Sana Biotechnology Inc Ordinary Shares | 0.05% | $3.16 | $958M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +171.20% | $8.57 | -29.67% | 1.98 |
168 | RIGL | Rigel Pharmaceuticals Inc | 0.05% | $39.31 | $758M | Biotechnology | Healthcare | N/A | 6.87 | 9.01 | N/A | N/A | N/A | 65 | +37.88% | $54 | -1.22% | 1.10 |
169 | ACRS | Aclaris Therapeutics Inc | 0.05% | $5.69 | $782M | Biotechnology | Healthcare | -15.62% | N/A | N/A | N/A | N/A | N/A | 75 | +75.75% | $10 | -18.28% | 0.86 |
170 | FDMT | N/A | 0.05% | $11.38 | $611M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +148.09% | $28 | -14.22% | 1.22 |
171 | ALLO | Allogene Therapeutics Inc | 0.04% | $1.85 | $465M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | 76 | +386.49% | $9 | -39.19% | 1.53 |
172 | ALT | Altimmune Inc | 0.04% | $2.82 | $374M | Biotechnology | Healthcare | -10.93% | N/A | 8.18 | 32.62 | N/A | N/A | 75 | +447.87% | $15 | -21.15% | 1.53 |
173 | DNA | Ginkgo Bioworks Holdings Inc | 0.04% | $7.89 | $556M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 25 | +7.73% | $8.50 | -54.33% | 2.33 |
174 | EDIT | Editas Medicine Inc | 0.04% | $2.89 | $349M | Biotechnology | Healthcare | -10.67% | N/A | N/A | N/A | N/A | N/A | 55 | +100.00% | $5.78 | -41.73% | 2.15 |
175 | SPRY | Ars Pharmaceuticals Inc | 0.04% | $6.36 | $750M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +320.60% | $27 | -28.22% | 1.16 |
176 | CADL | Candel Therapeutics Inc | 0.04% | $10.22 | $706M | Biotechnology | Healthcare | N/A | N/A | 43.48 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
177 | PACB | Pacific Biosciences Of California Inc | 0.04% | $1.40 | $475M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 57 | +75.57% | $2.46 | -46.30% | 1.95 |
178 | OPK | Opko Health Inc | 0.04% | $1.21 | $911M | Diagnostics & Research | Healthcare | N/A | N/A | 53.76 | N/A | N/A | N/A | 71 | +261.57% | $4.38 | -19.95% | 0.81 |
179 | DSGN | Design Therapeutics Inc | 0.04% | $12.06 | $844M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +74.13% | $21 | -7.33% | 1.13 |
180 | CTKB | Cytek Biosciences Inc | 0.04% | $4.57 | $601M | Medical Devices | Healthcare | N/A | N/A | 370.37 | N/A | N/A | N/A | 68 | +24.51% | $5.69 | 0.00% | 1.26 |
181 | MYGN | Myriad Genetics Inc | 0.04% | $5.91 | $596M | Diagnostics & Research | Healthcare | N/A | N/A | 54.05 | N/A | N/A | N/A | 50 | +5.75% | $6.25 | -28.74% | 1.06 |
182 | AURA | Aura Biosciences Inc | 0.03% | $7.03 | $430M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +167.43% | $19 | 0.00% | 1.11 |
183 | BBOT | Bridgebio Oncology Therapeutics Inc | 0.03% | $8.72 | $674M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +190.14% | $25 | 0.00% | 1.26 |
184 | CCCC | C4 Therapeutics Inc Ordinary Shares | 0.03% | $3.83 | $395M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +248.04% | $13 | -37.47% | 1.76 |
185 | CABA | Cabaletta Bio Inc Ordinary Shares | 0.03% | $2.82 | $463M | Biotechnology | Healthcare | +8.20% | N/A | N/A | N/A | N/A | N/A | 72 | +374.47% | $13 | -19.26% | 1.66 |
186 | ALVO | Alvotech | 0.03% | $3.52 | $1.12B | Drug Manufacturers - Specialty & Generic | Healthcare | -18.97% | N/A | 7.91 | N/A | N/A | N/A | 60 | +314.77% | $15 | 0.00% | 0.80 |
187 | ARVN | Arvinas Inc | 0.03% | $8.26 | $534M | Biotechnology | Healthcare | +1.07% | N/A | 17.86 | N/A | N/A | N/A | N/A | N/A | N/A | -37.19% | N/A |
188 | EBS | Emergent Biosolutions Inc | 0.03% | $7.63 | $408M | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.08 | 0.38 | N/A | N/A | N/A | +57.27% | $12 | -34.57% | 1.88 |
189 | PRME | Prime Medicine Inc | 0.03% | $3.12 | $630M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +128.21% | $7.12 | 0.00% | 2.10 |
190 | PRTA | Prothena Corp Plc | 0.03% | $8.75 | $447M | Biotechnology | Healthcare | -1.54% | N/A | 10.63 | N/A | N/A | N/A | N/A | +144.57% | $21 | -29.80% | 0.89 |
191 | RCKT | Rocket Pharmaceuticals Inc | 0.03% | $3.40 | $398M | Biotechnology | Healthcare | -5.96% | N/A | N/A | N/A | N/A | N/A | 53 | +176.18% | $9.39 | -41.34% | 1.35 |
192 | VNDA | Vanda Pharmaceuticals Inc | 0.03% | $5.48 | $352M | Biotechnology | Healthcare | N/A | N/A | 103.09 | N/A | N/A | N/A | 68 | +157.66% | $14 | -22.35% | 0.64 |
193 | SGMT | N/A | 0.03% | $7.07 | $181M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +270.58% | $26 | 0.00% | 1.87 |
194 | LAB | Standard Biotools Inc | 0.03% | $0.88 | $328M | Medical Devices | Healthcare | N/A | 4.26 | N/A | N/A | N/A | N/A | 62 | +75.32% | $1.55 | -25.34% | 1.57 |
195 | ENTA | Enanta Pharmaceuticals Inc | 0.03% | $13.42 | $384M | Biotechnology | Healthcare | +8.56% | N/A | 44.05 | N/A | N/A | N/A | 75 | +57.75% | $21 | -20.03% | 0.94 |
196 | NGNE | Neurogene Inc | 0.03% | $36.68 | $616M | Biotechnology | Healthcare | +11.24% | N/A | N/A | N/A | N/A | N/A | 75 | +122.76% | $82 | -25.83% | 1.87 |
197 | CTNM | N/A | 0.03% | $13.90 | $546M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +60.65% | $22 | 0.00% | 0.76 |
198 | FLGT | Fulgent Genetics Inc | 0.03% | $19.88 | $606M | Diagnostics & Research | Healthcare | N/A | N/A | 7.70 | N/A | N/A | N/A | 62 | -6.94% | $19 | -25.39% | 0.66 |
199 | KROS | Keros Therapeutics Inc | 0.02% | $10.57 | $218M | Biotechnology | Healthcare | +7.98% | N/A | 48.78 | N/A | N/A | N/A | 60 | +106.53% | $22 | -22.54% | 0.59 |
200 | KYTX | Kyverna Therapeutics Inc | 0.02% | $7.48 | $471M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +306.42% | $30 | 0.00% | 1.78 |
IBB (ISHARES BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
94.30%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%